NCT05413954 (Omegasnack) is a NA clinical trial of Control in Abdominal Obesity, sponsored by Université Catholique de Louvain.

Who is sponsoring NCT05413954?

NCT05413954 is sponsored by Université Catholique de Louvain.

What drugs are being tested in NCT05413954?

Interventions in NCT05413954: Control, Test.

What condition does NCT05413954 study?

NCT05413954 studies Abdominal Obesity.

Is NCT05413954 still recruiting?

NCT05413954 is currently completed. Last updated 10 June 2022.

Last reviewed 2022-06-10 · How we verify

NCT05413954: Omegasnack

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

To Evaluate the Health Effect of Particular Fatty Acids Profiles From Eggs

Completed NA Last updated 10 June 2022

What this trial tests

NA trial testing Control in Abdominal Obesity in 24 participants. Completed in 11 June 2021.

Timeline

22 October 2020

Primary endpoint
11 June 2021

11 June 2021

Quick facts

Lead sponsor	Université Catholique de Louvain
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	other
Enrollment	24
Start date	22 October 2020
Primary completion	11 June 2021
Estimated completion	11 June 2021
Sites	1 location across Belgium

Drugs / interventions tested

Control
Test — full drug profile →

Conditions studied

Abdominal Obesity — all drugs for Abdominal Obesity →

Sponsor

Université Catholique de Louvain — full company profile →

Who can join

Adults 18 to 75, any sex, with Abdominal Obesity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In a previous study, 24 volunteers consumed two conventional eggs or two eggs naturally enriched with omega 3, 5 and 7 every day for 3 months. It was shown that these eggs were well tolerated and that the omega enrichment led to a reduction in waist circumference of 3 cm in 3 months. The objective of Omegasnack study was therefore to go further in the evaluation of these effects on waist circumference; 1) confirm the effects of these eggs on waist circumference when included in a snack, 2) determine whether this reduction in waist circumference is linked to a reduction in muscle and/or fat mass (subcutaneous and/or visceral) and 3) evaluate whether these effects are associated with a modification in the accumulation of ectopic fat in the muscle and/or liver.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Effects of crackers enriched with polyunsaturated fatty acids with benefits for improving metabolic parameters: a double-blind randomised controlled trial in subjects with overweight.
Dénos C, Nain CW, Pachikian B, Hdidou S, et al · · 2026 · PMID 42235640 · DOI 10.1016/j.clnesp.2026.103370

Verify or expand the search:

Other trials of Control

Trials testing the same drug.

NCT06064604 — Clinical Efficacy of Exoskeleton Assistance for Individuals Post-Stroke · NA · not yet recruiting
NCT04039386 — Psychosocial Interventions for Young Adults With Hip Pain · NA · not yet recruiting
NCT07042373 — Effects of Tobacco Abuse Liability-dependent Taxes in the ETM · NA · not yet recruiting
NCT07512999 — The Effect of Using Nature Sounds and Virtual Reality During the Non-Stress Test · NA · not yet recruiting
NCT07531563 — Protein Supplementation for Radiation- Induced Oral Mucositis in Head and Neck Cancer Patients Receiving Radiotherapy · NA · not yet recruiting

Other recruiting trials for Abdominal Obesity

Currently open trials in the same condition.

NCT07383220 — Effect of Electrical Stimulation and Exercise on Blood Flow in Patients With Resistant High Blood Pressure · NA · recruiting
NCT07125716 — Suture Length Effects in Acupoint Implantation for Abdominal Obesity · NA · active not recruiting
NCT06554717 — Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV · Phase 2 · recruiting
NCT07092228 — Evaluation of Exercise Capacity in Teenage Females Using Virtual Reality and Plyometric Workout · NA · recruiting
NCT06359418 — Acupuncture for Prediabetes With Combined Obesity · NA · recruiting

Other Université Catholique de Louvain trials

Trials by the same sponsor.

NCT07453524 — Assessing Chronic Pain Patient Preferences · NA · not yet recruiting
NCT07422909 — Bridging the Gap: Implementing BRIDGES · NA · not yet recruiting
NCT07420231 — Evaluation of the Synergistic Effect of Combining a Prebiotic and a Postbiotic on Intestinal Discomfort · NA · not yet recruiting
NCT07360223 — Internalized Symptoms in Adolescents With Autism Spectrum Disorder (ASD) and Typically Developing Adolescents : Gaining · not yet recruiting
NCT07263971 — Birth Experience of Women Giving Birth in Belgium · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05413954 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Université Catholique de Louvain
Last refreshed: 10 June 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05413954.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing